المؤلفون: Rugo, Hope S, Trédan, Olivier, Ro, Jungsil, Morales, Serafin M, Campone, Mario, Musolino, Antonino, Afonso, Noémia, Ferreira, Marta, Park, Kyong Hwa, Cortes, Javier, Tan, Antoinette R, Blum, Joanne L, Eaton, Lamar, Gause, Christine K, Wang, Zhen, Im, Ellie, Mauro, David J, Jones, Mary Beth, Denker, Andrew, Baselga, José

المصدر: Breast Cancer Research and Treatment. 165(3)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Breast Cancer, Cancer, Clinical Trials and Supportive Activities, Clinical Research, Estrogen, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Adult, Aged, Aged, 80 and over, Androstadienes, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Breast Neoplasms, Female, Humans, Middle Aged, Neoplasm Staging, Retreatment, Sirolimus, Treatment Outcome, Breast cancer, Ridaforolimus, mTOR, Dalotuzumab, IGF1R, Exemestane, Oncology & Carcinogenesis, Clinical sciences, Oncology and carcinogenesis

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/9wm4f1w5Test

المؤلفون: Baselga, José, Morales, Serafin M, Awada, Ahmad, Blum, Joanne L, Tan, Antoinette R, Ewertz, Marianne, Cortes, Javier, Moy, Beverly, Ruddy, Kathryn J, Haddad, Tufia, Ciruelos, Eva M, Vuylsteke, Peter, Ebbinghaus, Scot, Im, Ellie, Eaton, Lamar, Pathiraja, Kumudu, Gause, Christine, Mauro, David, Jones, Mary Beth, Rugo, Hope S

المصدر: Breast Cancer Research and Treatment. 163(3)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Clinical Trials and Supportive Activities, Estrogen, Patient Safety, Clinical Research, Cancer, Breast Cancer, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Adult, Aged, Androstadienes, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Aromatase Inhibitors, Breast Neoplasms, Disease-Free Survival, Female, Humans, Middle Aged, Protein Kinase Inhibitors, Receptors, Estrogen, Sirolimus, Stomatitis, Ridaforolimus, mTOR, Dalotuzumab, IGF1R, Breast cancer, Oncology & Carcinogenesis, Clinical sciences, Oncology and carcinogenesis

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/9vz6j888Test

المؤلفون: Huang, Chao H, Williamson, Stephen K, Neupane, Prakash, Taylor, Sarah A, Allen, Ace, Smart, Nora J, Uypeckcuat, Adelina M, Spencer, Sarah, Wick, Jo, Smith, Holly, Van Veldhuizen, Peter J, Kelly, Karen

المصدر: Frontiers in Oncology. 5(JAN)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Clinical Research, Clinical Trials and Supportive Activities, Cancer, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, dalotuzumab, non-squamous cell lung cancer, metastatic, IGF-1R, pemetrexed, treatment, Clinical sciences, Oncology and carcinogenesis

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/6ns5b1j8Test

المؤلفون: Huang, Chao H, Williamson, Stephen K, Neupane, Prakash, Taylor, Sarah A, Allen, Ace, Smart, Nora J, Uypeckcuat, Adelina M, Spencer, Sarah, Wick, Jo, Smith, Holly, Van Veldhuizen, Peter J, Kelly, Karen

المصدر: Frontiers in oncology. 5(JAN)

مصطلحات موضوعية: IGF-1R, dalotuzumab, metastatic, non-squamous cell lung cancer, pemetrexed, treatment, Cancer, Clinical Trials and Supportive Activities, Clinical Research, 6.1 Pharmaceuticals, Oncology and Carcinogenesis

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/6ns5b1j8Test

المؤلفون: Chao H Huang, Stephen K Williamson, Prakash eNeupane, Sarah A Taylor, Ace eAllen, Nora J Smart, Adelina M Uypeckcuat, Sarah eSpencer, Jo eWick, Holly eSmith, Peter J Van Veldhuizen, Karen eKelly

المصدر: Frontiers in Oncology, Vol 5 (2016)

مصطلحات موضوعية: Treatment, Metastatic, IGF-1R, pemetrexed, dalotuzumab, Non-squamous cell lung cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://journal.frontiersin.org/Journal/10.3389/fonc.2015.00301/fullTest; https://doaj.org/toc/2234-943XTest

الوصول الحر: https://doaj.org/article/d6ef07d5512e44d4ba18480f63ccc3f9Test

المؤلفون: Morán, Teresa, Felip, Enriqueta, Keedy, Vicki, Borghaei, Hossein, Shepherd, Frances A., Insa, Amelia, Brown, Holly, Fitzgerald, Timothy, Sathyanarayanan, Sriram, Reilly, John F., Mauro, David, Hsu, Karl, Yan, Li, Universitat Autònoma de Barcelona

مصطلحات موضوعية: Non-small-cell lung cancer, Epidermal growth factor receptor, Insulin growth factor receptor, Dalotuzumab, Phase I/II trial

وصف الملف: application/pdf

العلاقة: Experimental Hematology & Oncology; Vol. 3 (november 2014); https://ddd.uab.cat/record/185123Test; urn:10.1186/2162-3619-3-26; urn:oai:ddd.uab.cat:185123; urn:pmid:25414803; urn:pmid:24387242; urn:pmcid:PMC4237770; urn:pmc-uid:4237770; urn:scopus_id:84983102615; urn:wos_id:000215299300026; urn:altmetric_id:2918164; urn:oai:egreta.uab.cat:publications/eab26b59-a712-4e54-8bf0-8b7e675f6c59; urn:oai:pubmedcentral.nih.gov:4237770

الإتاحة: https://ddd.uab.cat/record/185123Test

المؤلفون: José Baselga, Marianne Ewertz, Scot Ebbinghaus, Christine K. Gause, Joanne L. Blum, Antoinette R. Tan, Serafin Morales, Mary Beth Jones, Kumudu Pathiraja, Beverly Moy, Tufia C. Haddad, Ellie Im, Hope S. Rugo, Javier Cortes, David J. Mauro, Ahmad Awada, L Eaton, Eva Ciruelos, Kathryn J. Ruddy, Peter Vuylsteke

المصدر: Breast cancer research and treatment, vol 163, iss 3
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Baselga, J, Morales, S M, Awada, A, Blum, J L, Tan, A R, Ewertz, M, Cortes, J, Moy, B, Ruddy, K J, Haddad, T, Ciruelos, E M, Vuylsteke, P, Ebbinghaus, S W, Im, E, Eaton, L, Pathiraja, K, Gause, C K, Mauro, D, Jones, M B & Rugo, H S 2017, ' A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer ', Breast Cancer Research and Treatment, vol. 163, no. 3, pp. 535–544 . https://doi.org/10.1007/s10549-017-4199-3Test

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Phases of clinical research, chemistry.chemical_compound, Breast cancer, 0302 clinical medicine, Exemestane, IGF1R, Receptors, Antineoplastic Combined Chemotherapy Protocols, Monoclonal, Ridaforolimus, Humanized, Cancer, Aromatase Inhibitors, Antibodies, Monoclonal, Middle Aged, Receptors, Estrogen, 6.1 Pharmaceuticals, 030220 oncology & carcinogenesis, mTOR, Female, Patient Safety, Dalotuzumab, Adult, medicine.medical_specialty, medicine.drug_class, Clinical Trials and Supportive Activities, Clinical Sciences, Oncology and Carcinogenesis, Breast Neoplasms, Antibodies, Monoclonal, Humanized, Article, Antibodies, Disease-Free Survival, 03 medical and health sciences, Clinical Research, Internal medicine, medicine, Humans, Oncology & Carcinogenesis, Adverse effect, Protein Kinase Inhibitors, Aged, Sirolimus, Stomatitis, Aromatase inhibitor, business.industry, Evaluation of treatments and therapeutic interventions, medicine.disease, Estrogen, Androstadienes, 030104 developmental biology, chemistry, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f0c820c9a4a3dd16d5dbc64f6079bd5Test
https://doi.org/10.1007/s10549-017-4199-3Test

المؤلفون: Xiao Qu, Zhinan Wu, Jiajun Du, Wei Dong, Zhaofei Pang, Wei Ma, Liguang Wang, Tiehong Zhang

المصدر: Oncotarget

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Colorectal cancer, Review, cancer treatment, Receptor, IGF Type 1, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Breast cancer, Neoplasms, Internal medicine, medicine, Humans, curative effects, Aged, combination chemotherapy, Dalotuzumab, business.industry, Cixutumumab, Cancer, Combination chemotherapy, Middle Aged, Prognosis, medicine.disease, Survival Analysis, Surgery, Figitumumab, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, prognostic clinical trials, business, IGF-1R

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ac970cf5c70c3338a23b4b16e9f381aTest
https://doi.org/10.18632/oncotarget.15704Test

المؤلفون: Tormod Kyrre Guren, Josep Tabernero, Stephen Clarke, Tae Y. Kim, Andrey Loboda, Hans J. Schmoll, Tae W. Kim, Jan Erik Frödin, David Ferry, David Watkins, Mark Ayers, Young Suk Park, Eliza A Hawkes, JaeKyung Roh, David Cunningham, Sun Young Kim, Francesco Sclafani, Clare Peckitt, Michael Nebozhyn

المصدر: International Journal of Cancer. 140:431-439

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Pathology, Cetuximab, Dalotuzumab, business.industry, Colorectal cancer, Neutropenia, Placebo, medicine.disease, medicine.disease_cause, Irinotecan, 03 medical and health sciences, Exon, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, KRAS, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c4389946cdc6b70bc4a5e1c0f9876155Test
https://doi.org/10.1002/ijc.30453Test

المؤلفون: Jonathan D. Cheng, Lainie P. Martin, J. Fiorica, Raanan Berger, Paul Haluska, William S. Dalton, M. B. Jones, Shannon N. Westin, Lillian L. Siu, Talia Golan, J. Stephenson, Jhanelle E. Gray, Khaldoun Almhanna, R. M. Wenham, P. Hanjani, Alexandra Gunchenko, Daniel M. Sullivan, J. Edenfield, Irene Brana

المصدر: British Journal of Cancer

مصطلحات موضوعية: Male, Cancer Research, Akt inhibitor, Pharmacology, Receptor, IGF Type 1, Cohort Studies, chemistry.chemical_compound, MK-0752, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Benzene Derivatives, Medicine, Tissue Distribution, Sulfones, Randomized Controlled Trials as Topic, Aged, 80 and over, biology, Receptors, Notch, TOR Serine-Threonine Kinases, Antibodies, Monoclonal, Middle Aged, Discovery and development of mTOR inhibitors, Prognosis, ovarian cancer, Oncology, MK-2206, Female, Antibody, Heterocyclic Compounds, 3-Ring, Adult, colorectal cancer, Antibodies, Monoclonal, Humanized, Ridaforolimus, Clinical Trials, Phase II as Topic, ridaforolimus, Biomarkers, Tumor, Humans, In patient, Aged, Neoplasm Staging, dalotuzumab, Sirolimus, business.industry, Dalotuzumab, chemistry, Clinical Trials, Phase III as Topic, biology.protein, Clinical Study, Propionates, business, Proto-Oncogene Proteins c-akt, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f49b7b9125e9a40ceec15ef2e49d7c9Test
http://europepmc.org/articles/PMC4229637Test